Henry Hsu

Henry Hsu

Company: Allysta

Job title: Chief Executive Officer


Dissecting the Mediators of Adipose Tissue Dysregulation in Fibrosis: Role of Pro-Fibrotic & Anti-Fibrotic Adipocytokines 12:00 pm

• Excess adiposity is a risk factor for fibrosis of multiple organs including lung, liver, heart and kidney • These effects are mediated through a range of signalling proteins produced by adipocytes, many of which promotes chronic systemic inflammatory and fibrotic responses • Recent translational insights into pro-fibrotic and anti-fibrotic processes provide novel approaches for…Read more

day: Day Two

Panel Discussion: Reviewing the Validity & Reproducibility of Preclinical Models to Quantify Fibrosis & Translate Learnings from Preclinical Research to Clinical Study 4:25 pm

• Determining which preclinical models are more relevant to the human pathology to confirm viable therapeutic strategies that are translatable to humans • Evaluating to what degree new in vitro techniques are beneficial to bleomycin models • Assess associations of drug candidate with disease severity and outcomeRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.